First in man in vivo delivery of CRISPR-Cas9 targeting Transthyretin Amyloidosis
Authors: Dr Christos Georgiadis, October 2021. While this year has to most felt as though life came to a standstill, the field of genome editing has experienced unprecedented momentum. With CRISPR basking in the limelight following on from the joint…